{
  "id": 4964836,
  "title": "Ani Pharmaceuticals SVP & CFO Stephen Carey sells $207,480 in stock",
  "url": "https://urgent.news/2026/09/01/ani-pharmaceuticals-svp-cfo-stephen-carey-sells-207-480-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-01T23:30:55.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/ani-pharmaceuticals-svp--cfo-stephen-carey-sells-207480-in-stock-93CH-4884733"
  },
  "original_language": "en",
  "account": "Stephen P. Carey, the SVP & CFO of ANI Pharmaceuticals Inc., sold 2,850 shares of the company's common stock on August 31, 2026, earning $207,480. The trades were executed via a pre-approved plan on March 6, 2026, and resulted in Carey holding 171,843 shares of ANI Pharmaceuticals at the time of the sale. ANI Pharmaceuticals also reported robust second-quarter 2026 earnings, beating analyst projections with adjusted earnings of $2.21 per share versus an expected $2.03. Revenue reached a record $266 million, surpassing forecasts of $262.14 million. However, the company adjusted its full-year guidance for Cortrophin due to weak first-half performance, reducing expectations by $20 million to $25 million. Analysts maintained a Buy rating on the stock, with price targets adjusted slightly downward from $124 to $119 by Guggenheim and from $91 to $90 by Canaccord Genuity, citing Cortrophin underperformance as a concern. Despite the positive quarter results, analysts emphasized the need to monitor ANI Pharmaceuticals' future performance, particularly regarding Cortrophin sales.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Bill Holdings CFO Rohini Jain sells $1.6m of Bill stock",
        "url": "https://urgent.news/2026/09/01/bill-holdings-cfo-rohini-jain-sells-1-6m-of-bill-stock",
        "published": "2026-09-01T22:02:44.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}